Fierce Pharma Biopharma News & Insights
6 days ago · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Top 20 pharma companies by 2023 revenue - Fierce Pharma
There were changes at the top and the bottom of last year’s top 20 pharma rankings by revenue. And, in between, Novo Nordisk made a significant leap, jumping five spots propelled by skyrocketing ...
Top 10 most anticipated drug launches of 2024 | Fierce Pharma
Jan 29, 2024 · Every year, we tap Evaluate's annual preview report to assess the biggest potential new drugs of the year ahead. Typically, major pharmaceutical and biotechnology companies are featured, each ...
The top 20 drugs by worldwide sales in 2023 | Fierce Pharma
May 28, 2024 · It's been several years since COVID-19 vaccines from Pfizer and Moderna jumped to the top of the pharma industry's sales charts, displacing longtime stalwarts with unprecedented sales. But, as ...
Trump won a second term. What does it mean for biopharma?
Nov 6, 2024 · On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed to win the U.S. | Over his first term, Donald Trump advocated for ...
Gilead’s Kite shortens Yescarta manufacturing time with FDA nod
Jan 30, 2024 · The manufacturing upgrade comes as Kite works through an important launch for Yescarta as a second-line therapy for large B-cell lymphoma. Last month, the FDA allowed additional patient survival ...
FDA found contamination issues at Thermo Fisher NC plant
Oct 11, 2024 · During the agency's visit, the FDA identified several issues across multiple areas. For one, the facility had problems with some of its production procedures, one of which relates to monitoring ...
The top 10 vaccine companies worldwide - Fierce Pharma
What a difference five years—and a global pandemic—can make in reshaping an industry. When Fierce Pharma last published our rankings of the top vaccine players back in 2017, we highlighted the ...
The top 15 blockbuster patent expirations coming this decade
Looking out over the next decade, some of the biggest drugs in the industry will tumble off the patent cliff, putting pharma giants in the hot seat as investors clamor for their next blockbuster.
Amid GLP-1 craze, Novo and Mylan ink patent settlement in …
Oct 7, 2024 · With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their generic to Novo Nordisk's wildly popular Type 2 diabetes drug Ozempic.